Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nutritional Global Status and Its Impact in Crohn's Disease.
Prieto JMI, Andrade AR, Magro DO, Imbrizi M, Nishitokukado I, Ortiz-Agostinho CL, Dos Santos FM, Luzia LA, Rondo PHC, Leite AZA, Carrilho FJ, Sipahi AM. Prieto JMI, et al. Among authors: magro do. J Can Assoc Gastroenterol. 2021 Mar 23;4(6):290-295. doi: 10.1093/jcag/gwab006. eCollection 2021 Dec. J Can Assoc Gastroenterol. 2021. PMID: 34877468 Free PMC article.
Effectiveness and Safety of Tofacitinib in the Management of Ulcerative Colitis: A Brazilian Observational Multicentric Study.
Perin RL, Magro DO, Andrade AR, Argollo M, Carvalho NS, Damião AOMC, Dotti AZ, Ferreira SDC, Flores C, Ludvig JC, Nones RB, Queiroz NSF, Parra RS, Steinwurz F, Teixeira FV, Kotze PG. Perin RL, et al. Among authors: magro do. Crohns Colitis 360. 2022 Dec 19;5(1):otac050. doi: 10.1093/crocol/otac050. eCollection 2023 Jan. Crohns Colitis 360. 2022. PMID: 36777366 Free PMC article.
BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
Lomazi EA, Oba J, Rodrigues M, Marmo MCDR, Sandy NS, Sdepanian VL, Imbrizi M, Baima JP, Magro DO, Albuquerque IC, Zabot GP, Cassol OS, Saad-Hossne R. Lomazi EA, et al. Among authors: magro do. Arq Gastroenterol. 2023 Mar 24;59(suppl 1):85-124. doi: 10.1590/S0004-2803.2022005S1-04. eCollection 2023. Arq Gastroenterol. 2023. PMID: 36995890 Free article.
Vedolizumab in Mild-to-Moderate Crohn's Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study.
Dotti AZ, Magro DO, Vilela EG, Chebli JMF, Chebli LA, Steinwurz F, Argollo M, Carvalho NS, Parente JML, Lima MM, Parra RS, Perin RL, Flores C, Morsoletto EM, da Costa Ferreira S, Ludvig JC, Kaiser Junior RL, Faria MAG, Nicollelli GM, Andrade AR, Queiroz NSF, Kotze PG. Dotti AZ, et al. Among authors: magro do. Crohns Colitis 360. 2023 Sep 22;5(4):otad053. doi: 10.1093/crocol/otad053. eCollection 2023 Oct. Crohns Colitis 360. 2023. PMID: 37859629 Free PMC article.
Effectiveness and Safety of Ustekinumab for Ulcerative Colitis: A Brazilian Multicentric Observational Study.
Parra RS, Chebli JMF, de Azevedo MFC, Chebli LA, Zabot GP, Cassol OS, de Sá Brito Fróes R, Santana GO, Lubini M, Magro DO, Imbrizi M, Moraes ACDS, Teixeira FV, Alves Junior AJT, Gasparetti Junior NLT, da Costa Ferreira S, Queiroz NSF, Kotze PG, Féres O. Parra RS, et al. Among authors: magro do. Crohns Colitis 360. 2024 Apr 11;6(2):otae023. doi: 10.1093/crocol/otae023. eCollection 2024 Apr. Crohns Colitis 360. 2024. PMID: 38681979 Free PMC article.
Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.
Magro DO, Cazzo E, Kotze PG, Vasques ACJ, Martinez CAR, Chaim EA, Geloneze B, Pareja JC, Coy CSR. Magro DO, et al. Obes Surg. 2018 Feb;28(2):378-388. doi: 10.1007/s11695-017-2851-y. Obes Surg. 2018. PMID: 28776152
Adalimumab Serum Concentrations, Clinical and Endoscopic Disease Activity in Crohn's Disease: A Cross-Sectional Multicentric Latin American Study.
de Souza LR, Magro DO, Teixeira FV, Parra RS, Miranda EF, Féres O, Saad-Hossne R, Soares Prates Herrerias G, Nisihara RM, Coy CSR, Sassaki LY, Kotze PG. de Souza LR, et al. Among authors: magro do. Pharmaceutics. 2023 Feb 9;15(2):586. doi: 10.3390/pharmaceutics15020586. Pharmaceutics. 2023. PMID: 36839908 Free PMC article.
60 results